Literature DB >> 24275655

Homo-oligomerization of the activating natural killer cell receptor NKp30 ectodomain increases its binding affinity for cellular ligands.

Julia Herrmann1, Hannah Berberich, Jessica Hartmann, Steffen Beyer, Karen Davies, Joachim Koch.   

Abstract

The natural cytotoxicity receptors, comprised of three type I membrane proteins NKp30, NKp44, and NKp46, are a unique set of activating proteins expressed mainly on the surface of natural killer (NK) cells. Among these, NKp30 is a major receptor targeting virus-infected cells, malignantly transformed cells, and immature dendritic cells. To date, only few cellular ligands of NKp30 have been discovered, and the molecular details of ligand recognition by NKp30 are poorly understood. Within the current study, we found that the ectodomain of NKp30 forms functional homo-oligomers that mediate high affinity binding to its corresponding cellular ligand B7-H6. Notably, this homo-oligomerization is strongly promoted by the stalk domain of NKp30. Based on these data, we suggest that homo-oligomerization of NKp30 in the plasma membrane of NK cells, which might be favored by IL-2-dependent up-regulation of NKp30 expression, provides a way to improve recognition and lysis of target cells by NK cells.

Entities:  

Keywords:  B7-H6; Cancer Biology; Innate Immunity; Insect Cells; Membrane Proteins; NCR3; Natural Killer (NK) Cell; Protein Secretion; Protein Self-assembly; Stalk Domain

Mesh:

Substances:

Year:  2013        PMID: 24275655      PMCID: PMC3887203          DOI: 10.1074/jbc.M113.514786

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

Review 1.  Surface NK receptors and their ligands on tumor cells.

Authors:  Lorenzo Moretta; Cristina Bottino; Daniela Pende; Roberta Castriconi; Maria Cristina Mingari; Alessandro Moretta
Journal:  Semin Immunol       Date:  2006-05-26       Impact factor: 11.130

Review 2.  NK cells at the interface between innate and adaptive immunity.

Authors:  A Moretta; E Marcenaro; S Parolini; G Ferlazzo; L Moretta
Journal:  Cell Death Differ       Date:  2007-06-01       Impact factor: 15.828

3.  Mechanistic analysis of the antitumor efficacy of human natural killer cells against breast cancer cells.

Authors:  Keiko Kajitani; Yuka Tanaka; Koji Arihiro; Tsuyoshi Kataoka; Hideki Ohdan
Journal:  Breast Cancer Res Treat       Date:  2012-01-20       Impact factor: 4.872

Review 4.  Targeting natural killer cells and natural killer T cells in cancer.

Authors:  Eric Vivier; Sophie Ugolini; Didier Blaise; Christian Chabannon; Laurent Brossay
Journal:  Nat Rev Immunol       Date:  2012-03-22       Impact factor: 53.106

5.  Crystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2.

Authors:  G A Snyder; A G Brooks; P D Sun
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

6.  Dimerization of NKp46 receptor is essential for NKp46-mediated lysis: characterization of the dimerization site by epitope mapping.

Authors:  Michal Jaron-Mendelson; Rami Yossef; Michael Y Appel; Alon Zilka; Uzi Hadad; Fabian Afergan; Benyamin Rosental; Stanislav Engel; Shlomo Nedvetzki; Alex Braiman; Angel Porgador
Journal:  J Immunol       Date:  2012-05-21       Impact factor: 5.422

7.  Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1.

Authors:  Peter Lamken; Martynas Gavutis; Imke Peters; José Van der Heyden; Gilles Uzé; Jacob Piehler
Journal:  J Mol Biol       Date:  2005-07-15       Impact factor: 5.469

8.  Remodelling of cortical actin where lytic granules dock at natural killer cell immune synapses revealed by super-resolution microscopy.

Authors:  Alice C N Brown; Stephane Oddos; Ian M Dobbie; Juha-Matti Alakoskela; Richard M Parton; Philipp Eissmann; Mark A A Neil; Christopher Dunsby; Paul M W French; Ilan Davis; Daniel M Davis
Journal:  PLoS Biol       Date:  2011-09-13       Impact factor: 8.029

9.  p46, a novel natural killer cell-specific surface molecule that mediates cell activation.

Authors:  S Sivori; M Vitale; L Morelli; L Sanseverino; R Augugliaro; C Bottino; L Moretta; A Moretta
Journal:  J Exp Med       Date:  1997-10-06       Impact factor: 14.307

10.  The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans.

Authors:  Cameron S Brandt; Myriam Baratin; Eugene C Yi; Jacob Kennedy; Zeren Gao; Brian Fox; Betty Haldeman; Craig D Ostrander; Tomonori Kaifu; Christian Chabannon; Alessandro Moretta; Robert West; Wenfeng Xu; Eric Vivier; Steven D Levin
Journal:  J Exp Med       Date:  2009-06-15       Impact factor: 14.307

View more
  4 in total

Review 1.  Advances in NK cell production.

Authors:  Fang Fang; Siqi Xie; Minhua Chen; Yutong Li; Jingjing Yue; Jie Ma; Xun Shu; Yongge He; Weihua Xiao; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2022-01-05       Impact factor: 22.096

2.  The Stalk Domain of NKp30 Contributes to Ligand Binding and Signaling of a Preassembled NKp30-CD3ζ Complex.

Authors:  Stefanie Memmer; Sandra Weil; Steffen Beyer; Tobias Zöller; Eike Peters; Jessica Hartmann; Alexander Steinle; Joachim Koch
Journal:  J Biol Chem       Date:  2016-10-17       Impact factor: 5.157

Review 3.  Baseline and Dynamic Expression of Activating NK Cell Receptors in the Control of Chronic Viral Infections: The Paradigm of HIV-1 and HCV.

Authors:  Francesco Marras; Federica Bozzano; Maria Libera Ascierto; Andrea De Maria
Journal:  Front Immunol       Date:  2014-07-02       Impact factor: 7.561

Review 4.  Engineering of chimeric natural killer cell receptors to develop precision adoptive immunotherapies for cancer.

Authors:  J Obajdin; D M Davies; J Maher
Journal:  Clin Exp Immunol       Date:  2020-07-25       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.